Stocks
Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -0.64% | -38.8% | -29.9% | -50.2% | -30.4% | 428.9% | ||
| Changes by years, y/y, % | +15pp | -38pp | +9pp | -20pp | +20pp | +14.8% | |||
Ionis Pharmaceuticals. EBITDA margin, %
Ionis Pharmaceuticals. EBITDA margin, changes, pp
Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -91.2% | 33.2% | -65.9% | 2 270% | -47.7% | 428.9% | |
| Changes by years, y/y, % | +50pp | +22pp | +2 305pp | +43pp | ||||
| Changes by quarters, q/q, % | -56pp | +124pp | -99pp | +2 336pp | -2 317pp | |||
